Pharmaceutical

Filter

Current filters:

None

Popular Filters

6601 to 6625 of 7207 results

Additional investment in New Zealand health welcomed by pharma trade group

15-05-2012

New Zealand Prime Minister John Key yesterday announced a number of new initiatives which came to an…

Asia-PacificBiotechnologyHealthcarePharmaceutical

Takeda posts downturn in sales for FY 2012; forecasts operating profit slump

15-05-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) posted disappointing results for its fiscal…

FinancialPharmaceuticalTakeda Pharmaceuticals

Study shows benefit of new maintenance therapy for multiple myeloma

14-05-2012

Multiple myeloma is a form of cancer where the plasma cells in the bone marrow grow out of control, causing…

BiotechnologyCelgenelenalidomideOncologyPharmaceuticalResearchRevlimid

Potential treatment for painful side effect of diabetes unveiled by UK researchers

14-05-2012

An international team of scientists say that they have a deeper understanding of why diabetics suffer…

DiabetesPharmaceuticalResearch

Urgent need for enhanced thrombosis products in Europe, says F&S

14-05-2012

The increasing incidence of thrombosis, paralleled by the maturing life cycles of existing products,…

Cardio-vascularEuropeMarkets & MarketingPharmaceutical

Expropriation in the Hungarian pharmacy sector reviewed

14-05-2012

The change of regime in Hungary in 1989 brought the much expected changes in the field of the retail…

EuropeMarkets & MarketingPharmaceuticalRegulation

New margins for Pharma success in an emerging world

14-05-2012

The future of the established pharma lies in the emerging and growth markets but it's not the profits…

GlobalHealthcareMarkets & MarketingPharmaceutical

FDA advisory thumbs up for Gilead's once-daily Quad for HIV

14-05-2012

There was more good news for Gilead Sciences (Nasdaq: GILD), the world's largest maker of HIV drugs,…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalQuadRegulation

Cell Therapeutics' Pixuvri cleared in EU for NHL

14-05-2012

US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) last week received conditional marketing authorization…

BiotechnologyCell TherapeuticsEuropeOncologyPharmaceuticalPixuvriRegulation

Takeda's vedolizumab meets primary endpoints in Ph III Crohn's disease study

13-05-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) has reported positive top-line results from…

Gastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticalsvedolizumab

Seikagaku licenses lumbar disc herniation product to Kaken

13-05-2012

Japanese companies Seikagaku Corp (TYO: 4548) and Kaken Pharmaceutical (TYO: 4521) have concluded a basic…

Asia-PacificcondoliaseKaken PharmaLicensingPharmaceuticalSeikagaku

Big pharma and biotech increasingly tackling rare and niche diseases, new report finds

13-05-2012

Rare and niche diseases are being increasingly spotlighted by pharmaceutical and biotechnology corporations…

BiotechnologyPharmaceuticalRare diseasesResearch

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

EU draft opinion on ACTA still flawed, says MSF, urging member states not to sign

11-05-2012

The European Union Parliament Committee on Development released its draft opinion this week on the Anti-Counterfeiting…

EuropeGenericsGlobalPatentsPharmaceuticalPolitics

UK's NICE negative on Sanofi's Jevtana, but backs Botox for migraine

11-05-2012

Confirming previous negative guidance (The Pharma Letter January 12), UK drugs watchdog the National…

AllerganBotoxEuropeJevtanaNeurologicalOncologyPharmaceuticalPricingRegulationSanofi

Stada Arz reports solid start to 2012

10-05-2012

German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) reported first-quarter 2012 financial…

FinancialGenericsPharmaceuticalSTADA Arzneimittel

Allergan wins over EU trade marks for Botolist and Botocyl

10-05-2012

The was good news yesterday for USA-based Allergan (NYSE: AGN) when the European Court of Justice confirmed…

AllerganBotocylBotolistBotoxEuropePatentsPharmaceutical

US drug sponsors' regulatory experience was mixed during PDUFA IV, says Tufts CSDD

10-05-2012

Drug sponsors experienced a mixed regulatory burden under the Food and Drug Administration Amendments…

BiotechnologyNorth AmericaPharmaceuticalRegulation

Empty pipelines drive deal valuations in pharmaceuticals sector, say IMAP

10-05-2012

A drought of domestic growth opportunities and new products is inflating valuations for R&D companies…

BiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Impact of Japanese drug price reductions, by P Reed Maurer

10-05-2012

Outside observers have long predicted the mandated price reductions of drugs will kill the Japanese pharmaceutical…

Asia-PacificPharmaceuticalPricingRegulation

FDA advisory backs Pfizer's tofacitinib for RA

10-05-2012

The US Food and Drug Administration's Arthritis Advisory Committee yesterday voted eight to two to recommend…

Anti-Arthritics/RheumaticsNorth AmericaPfizerPharmaceuticalRegulationtofacitinib

6601 to 6625 of 7207 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top